Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis
- 29 January 2007
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 95 (2) , 167-174
- https://doi.org/10.1002/jso.20625
Abstract
Patients with cancer have an increased risk of developing venous thromboembolism (VTE) due to a hypercoagulable state associated with malignancy. This risk is further complicated in patients undergoing cancer‐related surgery due to immobility, other cancer treatments, and biologic changes associated with surgery. Despite this relatively high risk of VTE, many patients are not prescribed adequate prophylaxis in the pre‐ or post‐operative periods. This article reviews available measures for thromboprophylaxis in light of current guidelines. J. Surg. Oncol. 2007;95:167–174.Keywords
This publication has 52 references indexed in Scilit:
- Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgeryBritish Journal of Surgery, 2004
- Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgeryGynecologic Oncology, 2004
- Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE SurveyThe Oncologist, 2003
- Venous Thromboembolism and Cancer: Risks and OutcomesCirculation, 2003
- Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBritish Journal of Surgery, 2001
- Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgeryObstetrics & Gynecology, 2000
- Prevention of Venous Thromboembolism in Cancer PatientsSeminars in Thrombosis and Hemostasis, 1999
- Efficacy and safety of enoxaparinversus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessmentBritish Journal of Surgery, 1997
- Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparinBritish Journal of Surgery, 1996
- Prevalence of pulmonary embolism at necropsy in patients with cancer.Journal of Clinical Pathology, 1989